|
High drug prices in Canada are just one side of a bad equation
Tuesday, July 18th, 2023
To ensure that Canadians receive similar benefits from the pharmaceutical industry as other countries, we need oversight of both sides of the equation: drug prices (… fully protected from political influence), and follow-up to ensure any government programs intended to offer investment incentives for the pharmaceutical industry in the Canadian economy achieve their goals.
Posted in Health Policy Context | No Comments »
Ten reasons why we need pharmacare in tomorrow’s budget
Thursday, April 7th, 2022
The Liberals set up the Advisory Council on the Implementation of National Pharmacare which reported in early 2019, and then campaigned on pharmacare in the 2019 election. Still no pharmacare. Now, as the financial and medical costs of coping with the pandemic keep going up, pharmacare is more important than ever.
Tags: budget, economy, Health, ideology, jurisdiction, mental Health, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Lower drug prices are a priority for Canadians, but not for the federal government
Tuesday, January 25th, 2022
While the federal government has been bowing to the pharmaceutical industry, the amount that Canadians spend on medicines has continued to rise. In 2020, Canadians spent an estimated $32.7 billion, 4.3 per cent more than the previous year. Meanwhile, more than two-in-five Canadians are concerned about their ability to afford prescription drugs in 10 years.
Tags: Health, pharmaceutical, privatization, standard of living
Posted in Health Policy Context | No Comments »
Recent Comments